BioSpace News Archive

According to Nova one advisor, the global Molecular Diagnostics market was valued at USD 25.2 billion in 2022and it is expected to hit around USD 47.9 billion by 2030 with a CAGR of 14.1% during the forecast period 2022 to 2030.

According to the global Lyme Disease Treatment market size is expected to surpass around USD 4.1 billion by 2030 from valued at USD 1.85 billion in 2021 and growing at a CAGR of 6.2% from 2022 to 2030.

According to Nova one advisor, the global Medical Enzyme Technology market was valued at USD 4.7 billion in 2021 and it is expected to hit around USD 7.9 billion by 2027 with a CAGR of 6.2% during the forecast period 2022 to 2030.

According to the global Immuno-Oncology Clinical Trials market size is expected to surpass around USD 18.1 billion by 2030 from valued at USD 6.3 billion in 2021 and growing at a CAGR of 14.6% from 2022 to 2030.

SHINE Technologies, a next-generation fusion technology company, and SHINE Europe announced today that the Dutch government has approved a substantial grant proposal to develop a plan to produce a variety of terbium isotopes for use in nuclear medicine.

The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2022 of $0.98 per share on outstanding common stock.

BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”) today presented preclinical data for its two lead RAS programs – a next-generation KRASG12C dual inhibitor program and a novel PI3Kα:RAS breaker program – in an oral presentation at the Fourth RAS Initiative Symposium in Frederick, MD. BridgeBio will also be hosting an investor call at 1:30 ET today to discuss the data.

Applied BioMath (www.appliedbiomath.com), the industry-leader in providing model-informed drug discovery and development (MID3) support to help accelerate and de-risk therapeutic research and development (R&D), today announced their participation at AAPS 2022 PharmSci 360 occurring October 16-19, 2022 in Boston, MA.

Data scientist and statistician Katie Pollard, PhD, director of the Gladstone Institute of Data Science and Biotechnology, has been elected to the National Academy of Medicine, one of the highest honors in health and medicine.

iCRYO, the fast-growing recovery and wellness brand, recently recognized their top-performing franchisees at the company’s 1st Annual Elevate Conference that took place in League City, Texas from September 22nd to the 25th.